Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (5425)	5/31/1998 4:33:00 PM
From: Tai Jin	Read Replies (1) \| Respond to of 29382

BJCT > Assuming you are correct about the expense... Would you pay 1.00 more per injection so you or your children feel no pain??? Jim, Perhaps, but actually they do not state that this method reduces pain. Apparently, the biggest advantage for patients is a quick injection and reduction in fear (for those fearful of needles). There is an advantage in virtually eliminating accidental spread of pathogens from patient to healthcare worker. So I would say that the acceptance of this product must be driven by the healthcare industry rather than by patient demand. As I suspected, this technology has been around a long time and has been used in situations of mass innoculations. But BJCT has improved on the original technology by using a disposable syringe (the only part in contact with the patient's skin). They should have a market in these areas (military, UN health projects). I would say that the operational cost for this system is at least as much as the use of needles as there is still a disposable part and the use of C02 cartridges (6-10 injections per) and maintenance of the unit. However, I do think that needles will be replaced by a better injection system (perhaps BJCT's or something else) in the future. ...tai